Projects per year
Personal profile
Research interests
Miller Lab Consortium. To date, our team has treated more than 400 patients with natural killer cell infusions and over a hundred patients with therapies that activate their own natural killer cells. We've retrospectively analyzed more than 5000 patients and enrolled more than 500 patients in prospective trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 7 Affordable and Clean Energy
-
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
- 12 Similar Profiles
Collaborations and top research areas from the last five years
-
Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors
Antonarakis, E. (PI), Miller, J. S. (PI), Provenzano, P. (PI), Chen, C. C. (CoI), Cichocki, F. M. (CoI), Davis, Z. B. (CoI), Dehm, S. M. (CoI), Felices, M. (CoI) & Luo, X. (CoI)
8/1/23 → 7/31/30
Project: Research project
-
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
Blazar, B. R. (PI), Felices, M. (PI), Luo, X. (PI), Miller, J. S. (PI), Osborn, M. J. (PI), Rao, J. S. (PI), Wagner, J. E. (PI), Bachanova, V. (CoI), Betts, B. (CoI), Brunstein, C. G. (CoI), Cichocki, F. M. (CoI), De For, T. E. (CoI), Eaton, A. (CoI), Hippen, K. L. (CoI), Maakaron, J. (CoI), McKenna, D. H. (CoI), Shanley, R. M. (CoI), Tolar, J. (CoI), Zaiken, M. C. (CoI), Dougherty, P. R. (Graduate Student), Peng, Y. (Graduate Student), Le, C. T. (Prior Principal Investigator), Braun, J. A. (Other Role), Cao, Q. (Other Role), Dasgupta, T. (Other Role), Hinderlie, P. (Other Role), Jin, D. D. (Other Role), Kennedy, P. (Other Role), Kile, Q. (Other Role), Kopp, B. (Other Role), Lenvik, T. R. (Other Role), Meyer, C. M. (Other Role), Phung, G. (Other Role), Ramesh, V. (Other Role), Sleeth, M. L. (Other Role), Soignier, Y. M. (Other Role) & Xia, L. H. (Other Role)
5/5/23 → 4/30/28
Project: Research project
-
Minnesota Partnership for Biotechnology and Medical Genomics
Bischof, J. C. (PI), Cichocki, F. M. (PI), Dehm, S. M. (PI), Ebbini, E. S. (PI), Fischer, G. (PI), Garwood, M. (PI), Gurvich, V. J. (PI), Haynes, D. A. (PI), Hodges, J. S. (PI), Hwang, J. (PI), Johnson, M. D. (PI), Moriarity, B. S. (PI), Pacak, C. A. (PI), Pomerantz, W. C. (PI), Sarafoglou, K. M. (PI), Schumacher, R. J. (PI), Stromnes, I. M. (PI), Talkachova, A. (PI), Verma, V. (PI), Wang, J.-P. (PI), Webber, B. R. (PI), Wells, S. M. (PI), Wright, N. C. (PI), Begnaud, A. (Co-Principal Investigator), Cross, D. (Co-Principal Investigator), Karaca Mandic, P. (Co-Principal Investigator), Crawford, P. (Prior Principal Investigator) & LeBien, T. W. (Prior Principal Investigator)
7/1/21 → 6/30/27
Project: Research project
-
NK cells, their receptors, and cancer therapy
Cichocki, F. M. (PI), Felices, M. (PI), Geller, M. A. (PI), Grzywacz, B. J. (PI), Juckett, M. B. (PI), Luo, X. (PI), Miller, J. S. (PI), Rao, J. S. (PI), Walcheck, B. (PI), Weisdorf, D. J. (PI), Bachanova, V. (CoI), Basu, S. (CoI), Brunstein, C. G. (CoI), Davis, Z. B. (CoI), Kennedy, P. (CoI), Le, C. T. (CoI), Starr, T. (CoI), Warlick, E. D. (CoI) & De For, T. E. (Prior Principal Investigator)
4/9/21 → 3/31/27
Project: Research project
-
Bcl11b: A Master Transcription Factor Controlling Human NK Cell Development
Cichocki, F. M. (PI), Eaton, A. (CoI), Felices, M. (CoI) & Wang, J. (CoI)
NIH NATL HEART, LUNG AND BLOOD INSTITU
7/1/21 → 4/30/26
Project: Research project
-
# Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors
Lozada, J. R., Ali, A., Luo, C., Plagens, R. N., Zhang, B., Elliott, A., Boytim, E., Zorko, N. A., Heath, E. I., Patnaik, A., Vanderwalde, A. M., Antonarakis, E. S., Miller, J. S., Hwang, J. H. & Cichocki, F., Jun 1 2026, In: Cancer Immunology Research. 14, 6, p. 1008-1021 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Can natural killer cells cure leukemia?
Cichocki, F., Felices, M., Matson, A. W., Lee, M. J. & Miller, J. S., Aug 2026, In: Leukemia. 40, 8, p. 1600-1603 4 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Dynamics of natural killer cell function upon recurrent stimulation
One, J., Narayan, J., Cichocki, F., Hu, W. S. & Azarin, S. M., Mar 1 2026, In: Biotechnology Progress. 42, 2, e70100.Research output: Contribution to journal › Article › peer-review
Open Access -
Chimeric antigen receptor therapies: Development, design, and implementation
Lee, M. J., Cichocki, F. & Miller, J. S., Jul 2025, In: Journal of Allergy and Clinical Immunology. 156, 1, p. 70-80 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access7 Link opens in a new tab Scopus citations -
Chronic NK cell activation results in a dysfunctional, tissue resident–like state mediated by KLF2 deficiency
Myers, J. A., Huang, R. S., Phung, S. K., Chacón, J. M., Bendzick, L., Weis, A., Shetty, M., DePauw, T. A., Khaw, M. J., Abrahante, J. E., O’Flanagan, S. D., Ashby, K. M., Lozada, J. R., Jameson, S. C., Hwang, J. H., Cichocki, F., Felices, M. & Miller, J. S., Dec 18 2025, In: Blood. 146, 25, p. 3059-3071 13 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations